SLAM
HALO icon

Swiss Life Asset Management’s Halozyme HALO Stock Holding History

Swiss Life Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$566K Sell
7,225
-3,616
-33% -$247K ﹤0.01% 898
2026
Q1 		$701K Buy
10,841
+1,809
+20% +$128K ﹤0.01% 750
2025
Q4 		$608K Buy
9,032
+3,217
+55% +$216K ﹤0.01% 737
2025
Q3 		$426K Buy
+5,815
New +$386K ﹤0.01% 765

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Swiss Life Asset Management's HALO Position: Q2 2026 in Review

Swiss Life Asset Management reduced its Halozyme (HALO) stake by 33% in Q2 2026, selling an estimated $247K and leaving 7,225 shares worth $566K. The position accounts for ﹤0.01% of the portfolio, ranked #898.

Swiss Life Asset Management first reported a position in HALO in Q3 2025 and has held it in 4 quarters since. The position peaked at $701K in Q1 2026. 528 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Swiss Life Asset Management held 7,225 shares of Halozyme worth $566K as of Q2 2026.
  • Swiss Life Asset Management sold 3,616 Halozyme shares in Q2 2026, an estimated $247K.
  • Halozyme made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #898 holding.
  • Swiss Life Asset Management first reported a position in Halozyme in Q3 2025 and has held it in 4 quarters since.
  • Swiss Life Asset Management's Halozyme position peaked at $701K in Q1 2026.
  • 528 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.